| Patents for C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722) |
|---|
| 05/12/2004 | EP1417223A1 Process for preparing lipid ii |
| 05/06/2004 | EP1414824A1 Novel anticonvulsant derivative salts |
| 05/05/2004 | CN1148376C Process for preparing clindamycin-2-benzyl phosphate |
| 05/04/2004 | CA2098882C Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonates |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/22/2004 | WO2004005308A3 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 04/21/2004 | EP1409496A1 Phosphoglycan messengers and their medical uses |
| 04/14/2004 | EP1408116A1 Novel sulfated saccharide and process for producing the same |
| 04/14/2004 | EP1301522A4 Novel compounds and methods |
| 04/07/2004 | EP1405855A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 04/07/2004 | EP1105401B1 Phosphoglycolipid and methods for its use |
| 03/31/2004 | EP0793668B1 Derivatives of carbohydrates and compositions containing them |
| 03/25/2004 | WO2003066647A3 Synthesis of inositolphosphate glycan molecules: treatment of cell proliferation disorders and metabolic disorders characterized by insulin resistance |
| 03/18/2004 | WO2004022531A1 Gentle sulphating method |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/09/2004 | US6703213 Substrate analogs for MurG, methods of making same and assays using same |
| 03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/19/2004 | DE10237412A1 Production of sulfated alcohols, useful as mild anionic surfactants in detergents or cosmetics, involves reaction of alcohols with acid sulfation products capable of transferring acid sulfate groups to the alcohol |
| 02/12/2004 | WO2003104247A3 Treatment of congenital disorders of glycosylation (cdg) using mannose |
| 02/05/2004 | WO2004011662A1 Persulfated oligosaccharide acting on selectins and chemokine |
| 02/05/2004 | CA2493639A1 Persulfated oligosaccharide acting on selectins and chemokine |
| 02/04/2004 | CN1472218A Medicine compound for preventing diabets mellitus and preparing method thereof |
| 02/03/2004 | US6686463 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 01/28/2004 | CN1136224C Inositolglycuns having insulin-like action |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |
| 01/22/2004 | WO2004007713A1 Nucleoside or nucleotide having novel unnatural base and utilization of the same |
| 01/21/2004 | EP1381620A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 01/21/2004 | EP0853627B1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 01/20/2004 | US6680304 Glucosamine derivative; antiinflammatory, antiarthritic, and anticoagulant agents |
| 01/15/2004 | WO2004005308A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 01/15/2004 | CA2492446A1 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 01/14/2004 | EP1380641A1 Sulfated fucoglucuronomannan |
| 12/30/2003 | CA2076063C Sulfated glycosaminoglycanoid derivatives |
| 12/25/2003 | US20030236223 For slowing tumor growth, decreasing cell proliferation, decreasing neovascularization and blocking metastatic spread |
| 12/24/2003 | WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a |
| 12/18/2003 | WO2003104247A2 Treatment of congenital disorders of glycosylation (cdg) using mannose |
| 12/10/2003 | EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa |
| 12/10/2003 | EP0795560B1 Keratan sulfate oligosaccharide fraction and drug containing the same |
| 10/23/2003 | WO2003086283A2 Metastasis modulating activity of highly sulfated oligosaccharides |
| 10/23/2003 | CA2481306A1 Metastasis modulating activity of highly sulfated oligosaccharides |
| 10/22/2003 | CN1450076A Oligose polysulfate and preparation process thereof |
| 10/21/2003 | US6635622 Having anti-tumor activity and immunostimulating activity |
| 09/25/2003 | WO2003070738A3 Topiramate salts and compositions comprising and methods of making and using the same |
| 09/25/2003 | WO2003011844A3 Reagent and method for perfluoroalkylation |
| 09/25/2003 | US20030181417 Nitroderivatives of polysaccharides |
| 09/25/2003 | US20030181400 Novel disaccharides with anti-arthrosic properties |
| 09/24/2003 | EP0969871B1 Method for the production of homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances |
| 09/18/2003 | WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 09/18/2003 | US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man |
| 09/18/2003 | US20030176362 For therapy of epilepsy |
| 09/17/2003 | EP1343485A2 Lipid-based nitric oxide donors |
| 09/04/2003 | WO2003072611A1 Nitro-derivatives of oligosaccharides |
| 09/04/2003 | US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation |
| 09/03/2003 | EP1340770A1 Nitro-derivatives of oligosaccharides |
| 08/28/2003 | WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 08/28/2003 | CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same |
| 08/21/2003 | WO2003068243A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| 08/21/2003 | CA2476383A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| 08/20/2003 | EP1335939A1 Nitroderivatives of polysaccharides |
| 08/19/2003 | US6608032 Medicinal compositions |
| 08/14/2003 | WO2003066647A2 Synthesis of inositolphosphate glycan molecules: treatment of cell proliferation disorders and metabolic disorders characterized by insulin resistance |
| 08/06/2003 | CN1117096C Oligo-Amorphophallus rivieri glucomajnnan glycan aldehydic acid propyl ester sodium sulfovindte and preparation and use thereof |
| 07/31/2003 | WO2003062412A1 Sulfated fucan |
| 07/31/2003 | US20030144503 Antiinflammatory agents |
| 07/30/2003 | EP1091969A4 Glucosamine sulfate metal chloride compositions and processes of preparation thereof |
| 07/30/2003 | CN1433306A Anticonvulsant derivatives useful in treating essential tremor |
| 07/29/2003 | US6599533 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof |
| 07/29/2003 | CA2098888C Process for separating 2-deoxy-2,2-difluoro-d-ribofuranosyl alkylsulfonate anomers |
| 07/29/2003 | CA2098885C Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-arylsulfonates |
| 07/24/2003 | US20030139356 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 07/17/2003 | US20030134805 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/10/2003 | WO2002048331A3 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars |
| 06/25/2003 | EP1021388B1 Phosphorylation process and catalyst |
| 06/24/2003 | CA2130805C Use of mannose phosphates for the treatment of fibrotic disorders |
| 06/12/2003 | US20030108595 Prevent deposits of amyloid; using sulfonate or sulfate compound |
| 06/05/2003 | US20030105032 Administering compound selected from MonoPhosphoryl Lipid A (MPL) and Serinol Aminoalkyl Glucosaminide Phosphate compound (AGP) for prophylaxis and therapy of infectious disease, autoimmune disease or allergic condition |
| 05/30/2003 | WO2003044032A1 Sugar derivative |
| 05/28/2003 | EP1313752A2 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 05/28/2003 | EP1014996B1 Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses |
| 05/15/2003 | US20030092759 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 05/14/2003 | EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 05/13/2003 | US6562954 Oligosaccharide for use as tool in human therapeutics |
| 05/08/2003 | US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 05/06/2003 | US6559293 Topiramate sodium trihydrate |
| 05/02/2003 | EP1032579B1 Carbohydrate derivatives |
| 04/17/2003 | WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 04/16/2003 | EP1301522A1 Novel compounds and methods |
| 04/10/2003 | US20030069414 Compound for use in the diagnosis and treatment of viral, bacterial and cancer diseases |
| 04/10/2003 | US20030069190 Alkali and alkaline earth metal salts of topiramate |
| 04/09/2003 | EP1300411A1 Novel disaccharides with anti-arthritic action |
| 04/03/2003 | WO2003026676A1 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 04/03/2003 | CA2461539A1 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 03/26/2003 | EP0841931B1 Pharmaceutical composition |
| 03/20/2003 | WO2003022860A1 Synthetic heparin pentasaccharides |
| 03/20/2003 | US20030055235 Genetically engineered transferase for use as tool in genetic engineering |
| 03/20/2003 | CA2806723A1 Synthetic heparin pentasaccharides |
| 03/20/2003 | CA2806604A1 Synthetic heparin pentasaccharides |